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Abstract
Epigenetic Tracking is a mathematical model of biological cells, originally conceived
to study embryonic development. Computer simulations proved the capacity of the model
to generate complex 3-dimensional cellular structures, and the potential to reproduce the
complexity typical of living beings. The most distinctive feature of this model is the pres-
ence in the body of a homogeneous distribution of stem cells, which are dinamically and
continuously created during development from non-stem cells and reside in niches. Em-
bryonic stem cells orchestrate early developmental events, adult stem cells direct late de-
velopmental and regeneration events, ageing stem cells cause ageing and cancer stem cells
are responsible for cancer growth. The conceptual backbone provided by Epigenetic Track-
ing brings together a wide range of biological phenomena: for this reason, we think it can
be proposed as a general model for multicellular biology. Despite, or perhaps due to its
theoretical origin, the model allowed us to make predictions relevant to very diverse fields
of biology, such as transposable elements, and cancer-related patterns of gene mutations.
This paper contains a summary of the model and its implications.
1 Introduction
This work is concerned with a biological model called Epigenetic Tracking (ET), described
in [6, 7, 8, 9, 10, 11, 12, 13, 14]. While the study of life sciences often relies on a bottom-
up method, that tries to infer general rules starting from genes and proteins, our work is
informed by a top-down approach, that proceeds from high-level abstractions towards a pro-
posal for biological, low-level molecular processes. As a consequence our model may contain
ingredients not necessarily adherent to current knowledge, but which can become a sugges-
tion for biologists to look into new, previously unexplored directions.
The capacity of the model to generate complex cellular structures was proved through
computer simulations. If we interpret such structures as a metaphor for biological organisms,
we can see in this endeavour the potential to reproduce the complexity typical of living beings.
Furthermore, ET is able to interpret with a unified framework a wide array of biological
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2 DEVELOPMENT
Figure 1: Developmental events. When in a stem cell the mobile code matches with the regulatory
set of a macro gene and the clock matches with the timer, the stem cell gets activated and performs
actions encoded in the coding part of the gene. Upon activation, stem cells (with mobile code A, marked
in yellow in panel L), can induce normal cells (in orange) to proliferate (panel M) or to differentiate
(not shown). Other stem cells, with a different mobile code (B), are generated from normal cells at a
subsequent stage (panel R). The mobile code is present also in normal cells, but it is active in stem
cells only.
phenomena, such as development, the presence of junk DNA, ageing and cancer: for this
reason, we think it can be proposed as a general model for multicellular biology. This paper
is divided into six sections: this (first) section is the introduction; section 2 describes ET as
a model of development; section 3 is dedicated to the evo-devo process; section 4 deals with
ageing; section 5 explores the topic of cancer; section 6 draws the conclusions and outlines
future directions.
2 Development
Hox genes are a family of regulatory genes, characterised by the presence of a DNA sequence
called homeobox. In early embryogenesis, Hox gene regulation is achieved through the mater-
nal factors present in the fertilised egg, gap and pair-rule genes [26]. In sebsequent phases of
development this role is taken over by morphogens, a class of compounds (e.g., BMP, Hedge-
hog, Notch, Wnt) which spread from localised sources and form concentration gradients, used
by cells to induce the expression of specific genes, through a characteristic “morphogenetic
code” [16].
Growth factors are a class of molecules which during embryonic development act locally,
either as paracrine or autocrine regulatory chemical messengers, as important regulators of
cellular proliferation and differentiation [28]. It is hypothesised that each organ or organ part
requires the action of a specific subset of growth factors. Each morphogen and growth factor is
processed by a dedicated signalling pathway, that starts when a ligand binds a receptor on the
cell surface, and ends in the nucleus, where the induced signal participates in the regulation
of target genes.
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In biological development a pivotal role is known to be played by stem cells, a class of cells
found in most multicellular organisms. Embryonic stem cells are totipotent cells found in the
inner cell mass of the blastocyst. Adult stem cells are pluripotent undifferentiated cells found
in “niches” throughout the body, where a particular microenvironment is required to maintain
the stem state [29]. The question of when and how adult stem cells are formed remains an
open issue in biology.
In ET development starts from a single cell and unfolds in a predefined number of devel-
opmental stages, counted by a global clock shared by all cells. Artificial bodies are composed
of two categories of cells: normal cells and stem cells. Cells have a variable called mobile code
(MOC), which can take different values in different cells (different mobile codes are shown
with different letters). The mobile code is present also in normal cells, but it is active in stem
cells only.
The mobile code can be interpreted in biology as the set of master transcription factors
present in a cell, which are responsible for the orchestration of developmental events. In our
model the mobile code is hypothesised to be composed of Hox proteins (in nature this may be
true in early embryogenesis, while at later stages the master role may be played also by other
elements). The clock represents a further transcription factor, carrying a temporal condition
for gene activation.
Stem cells direct development. In ET, this is achieved through the interaction of the mo-
bile code and the clock with a set of macro genes (Fig. 1). Each macro gene has a variable
called regulatory set, that can match with the mobile code, a variable called timer, that can
match with the clock, and a coding part. When a match occurs in a given stem cell, the cell
gets activated and a specific developmental event (encoded in the coding part of the gene) is
orchestrated. Macro genes have also a switch (not shown in the figure): when the switch is in
the OFF position, the gene is inactive. Macro genes are hypothesised to correspond in biology
to sets of genes co-regulated in space and time, involved in the production of growth factors
(the key regulators of biological developmental events).
When stem cells are activated (Fig. 1), they induce normal cells present in the volume
nearby to proliferate or to differentiate. If no normal cells are present in the volume, they can
be generated by stem cells through several rounds of asymmetric cell divisions (i.e. the stem
cell produces another identical stem cell and a normal cell). Subsequently, some normal cells
revert to stem cells, and receive new mobile codes. Some of these newly formed stem cells can
become the centre of other developmental events at a later stage, and development can move
ahead. Hence, in ET the normal-stem transition is a two-way street.
The set of stem cells and mobile codes generated during development has a hierarchical,
or tree, structure (Fig. 2). This feature appears consistent with the information we have on
the set of biological stem cells involved in the generation of particular organs or systems, such
as the hematopoietic system [27]. Our model provides also a means to bridge the conceptual
gap between embryonic and adult stem cells: embryonic stem cells correspond to elements
in the tree near the root, while adult stem cells correspond to the leaves of the tree. It also
explains how adult stem cells are generated, with the mechanism of conversion from normal
cells.
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Figure 2: Set of stem cells created during development. Stem cells marked in green become active
during development. As a result, they create normal cells and induce their differentiation. In parallel,
other stem cells are created.
This abstract model of development can be refined by linking the cellular behaviour with
modules which reproduce specific intracellular mechanisms, such as Hox genes, morphogen-
and growth factor-related pathways. A scheme of the interplay of these factors and their
relation to the phenomena of stem activation and stem formation is reported in Fig. 3. The
mobile code of a stem cell can trigger the activation of the growth factor production module,
dedicated to the production of growth factors (Fig. 3, upper panel, left part). This module
contains the macro genes described above. The growth factors exit the cell and are received
by a neighbouring normal cell (Fig. 3, upper panel, right part), and are processed by dedicated
growth factor (GF) modules. As a result, the cell enters the cell cycle and/or activates other
genes needed for differentiation.
In ET the process of normal-stem conversion is achieved through the presence of simu-
lated morphogens, with the following mechanism. Some stem cells (Fig. 4) become sources
of specific morphogens (belonging to a number of distinct types). These signals partition the
space into regions, each characterised by a distinct combination of concentration values. For
example, all cells in a given region “sense” one morphogen with concentration 7, another mor-
phogen with concentration 4, etc. (concentration values are integer numbers which represent
categories or ranges of actual concentration values). In each region a normal cell is selected
and turned into a stem cell.
Morphogen processing (MP) modules are dedicated to the processing of morphogens. For
simplicity we represented only four MP modules, named as the corresponding biological path-
ways (BMP, Hedgehog, Notch and Wnt). The process of new stem formation starts when a
normal cell receives morphogens from the external environment (Fig. 3, middle panel, left
part). These signals are processed by the MP modules and by the Hox module. The outcome
is represented by one or more Hox proteins, which are added to the repertoire of master tran-
scription factors already present in the cell, and contribute to determine the new mobile code
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Figure 3: Upper panel: stem activation. On the left side, a stem cell is activated and releases growth
factors into the external environment. On the right side, the growth factors are received by neighbour-
ing normal cells, which are induced to proliferate or to differentiate. Middle panel: stem formation.
On the left, a normal cell receives morphogens from the external environment. Their interplay deter-
mines the creation of a new Hox protein, which contributes to determine the establishment of a new
mobile code (on the right). Lower panel: example of tissue development composed of two rounds of
the stem activation-stem formation cycle.
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Figure 4: Morphogens in ET. The panel on the left shows a hypothetical distribution of stem cells.
Some of these stem cells (dashed circles) emit morphogens, of a finite number of types, which diffuse
across the space. On the right, the different combinations of concentration values of the morphogens
partition the space into regions (marked each with a different colour). In each such region a new stem
cell is created from a normal cell (red circles).
Figure 5: Self-generation and self-regeneration of a lizard-shaped structure consisting of 500000 cells
in ET. Development unfolds from a single cell (circle) in 12 developmental stages (frames 1-12). After
stage 12, the head and the tail are cut off (arrows). After the “debris” is removed, the structure is
completely regenerated.
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(Fig. 3, middle panel, right part). The lower panel shows an example of tissue development,
obtained with two rounds of the stem activation-stem formation cycle described.
According to this model, in biological cells each MP pathway senses the concentration of
a specific morphogen, and sends a signal into the nucleus. Here the interplay of signals con-
veyed by all pathways results in the transcription of a different Hox gene. For example, if the
combination of concentrations is [2130] (i.e. one morphogen is received with concentration 2,
another morphogen with concentration 1, etc.) Hox gene X is transcribed. If the combina-
tion of concentrations is [3110], Hox gene Y is transcribed. The particular combinations of
morphogen concentrations necessary for mobile code generation may correspond to the set of
signals required to maintain stem cells in niches [29].
ET foresees that each organ or anatomical structure of the body is assembled during em-
bryogensis thanks to the cooperation of a set of morphogens and a set of growth factors, which
are organ-specific. Table 1 gives an overview of a hypothetical involvement of four morphogens
(a, b, c, d) and four growth factors (p, q, r, s) in four organs. For each organ three morphogens
and three growth factors are hypothesised to be necessary to achieve development and differ-
entiation of all organ components. We hypothesise that this is true also in biological systems.
organ organ 1 organ 2 organ 3 organ 4
morphogens involved a,b,c a,b,d a,c,d b,c,d
growth factors involved p,q,r p,q,s p,r,s q,r,s
Table 1: Hypothetical involvement of morphogens and growth factors in the embryonic development
of four organs.
The proposed framework allows also to model cellular regeneration. Our concept of regen-
eration is based on the idea to recreate exactly the same conditions as during development.
Stem cells, after their activation during development, are kept in a deactivated state (so that
the associated event is not triggered again): these correspond in nature to adult stem cells.
Once a damage is detected in a given body part, the stem cells activated to produce that body
part during development are reactivated during regeneration, leading to the same sequence
of events, and restoration of the damaged part (Fig. 5).
3 Evo-devo and transposable elements
The model of development described can be coupled with a genetic algorithm, able to sim-
ulate Darwinian evolution. The genetic algorithm evolves a population of individuals (each
encoded in an artificial genome) for a number of generations. At each generation, all individ-
uals develop independently from the zygote stage to the final phenotype, whose proximity to
a predefined target is employed as a fitness measure. This operation is repeated for all indi-
viduals, so that eventually each individual is assigned a fitness value. Based on this value
the genomes of the individuals are selected and randomly mutated, to produce a new popula-
tion. This cycle is repeated until a satisfactory level of fitness is reached. The coupling of the
model of development and the genetic algorithm gives origin to an evo-devo process, which
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Figure 6: Examples of structures generated using ET. The panels show some stages of development
from the single cell stage (yellow circles) for three structures. The structures, composed of millions of
cells, represent a stomach, a hand, and a dog patterned with the colours of the Italian flag. This last
one is a more complex version of the classical Wolpert’s French frag model.
was proved able through computer simulations to “devo-evolve” 3-dimensional structures of
unprecedented complexity (see examples in Fig. 6).
In ET most stem cells produced during development do not orchestrate any events (are
inactive), because in the genome there is no macro gene whose regulatory set can match
their mobile code (upper left part of Fig. 7). The probability that a suitable regulatory set
(which is encoded as a long sequence of numbers) emerges in the genome simply through
mutations and recombinations is very low. A countermeasure consists in “suggesting” to the
genetic algorithm to put in the genome some regulatory sets which are guaranteed to match.
This idea is implemented in a procedure called germline penetration, which builds regulatory
sets able to match mobile codes generated during the development of the structure. These
regulatory sets are then associated to macro genes contained in a special copy of the genome
called “germline” genome (upper right part of Fig. 7) which, after reproduction, is destined to
become the (“somatic”) genome of the individuals of the next generation.
Once evolution is provided with a “good” regulatory set, i.e. one guaranteed to match an
existing mobile code, it has to optimise the coding part of the macro gene, a process that can
take several generations. When the optimisation of the coding part is completed, the new
macro gene can be activated and carry out a developmental event (lower part of Fig. 7). New
mobile codes are generated as a result of the new event: regulatory sets able to match such
new mobile codes are again transferred to the germline genome, and the whole cycle repeats
itself. The penetrated macro genes are initially set as inactive; otherwise, the gene would
become active with a non-optimised coding part, causing a disruption in development (and
an abrupt decrease in the individual’s fitness). Their activation is obtained through a sub-
sequent genomic mutation of the switch. Therefore, according to ET, evolution is essentially
Lamarckian for regulatory sequences and Darwinian for coding sequences.
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Figure 7: Germline penetration of new regulatory sets in ET. In the upper part, in a stem cell the
genome is not able to “respond” to the mobile code M with a corresponding event. A new regulatory set
able to respond is created in the stem cell. The new regulatory set leaves the stem cell and reaches the
germline, where it is incorporated in the genome. In a subsequent generation, when a cell has mobile
code M, its genome (inherited from the penetrated germline) can respond with a specific macro gene.
The result is a proliferation event.
Germline penetration is essential in ET for the evolution of complex shapes: in our in silico
experiments, if germline penetration is disabled, the evolutionary process practically grinds
to a halt. The central role played by germline penetration in our model lead us to hypothesise
the existence of a similar process also in biological organisms. For the implementation of
a biological germline penetration, we need genetic elements able to build new regulatory
sequences in somatic cells, and susceptible of being transferred to germline cells.
Transposable elements, or transposons [24], are DNA sequences that can move around to
different positions in the genome. During this process, they can cause mutations, chromo-
somal rearrangements and lead to an increase in genome size. Despite representing a large
genomic fraction (30-40% in mammals), transposons have no clear biological function, and
have therefore been labelled as “junk DNA”. Transposable elements are active during devel-
opment, and may bring diversity in somatic cells having the same genome [2]. A transposonal
activity was also observed in germline cells, with possible evolutionary implications. “Waves”
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of diffusion of transposable elements in a genome appear temporally associated with major
evolutionary changes to the species [25], suggesting a causal link between the two events.
Based on these considerations, we can imagine a mechanism for the implementation of a
biological germline penetration. In a stem cell unable to produce a developmental event (be-
cause the set of master transcription factors present in the cell cannot bind to corresponding
regulatory sequences), transposable elements would become mobilised, and start “jumping”
around the genome. This process could lead to the creation of many new regulatory sequences,
hugely increasing the chances that a lucky combination of such sequences be able to match the
existing transcription factors. We hypothesise that, when a match occurs, the transposable el-
ements which helped to build the new sequences leave the cell and, through the bloodstream,
make their way to germline cells. Here they insert themselves into the genome, thus allowing
the delivery of a successful innovation to the next generation.
The mechanism described has interesting evolutionary implications. In ET, whenever a
stem cell proliferates, a wave of new stem cells, with new mobile codes, is created in the
body of the (new) species. The action of germline penetration translates this wave of new
mobile codes in somatic cells into a corresponding wave of new regulatory sets spreading in
the germline genome and subsequently in the somatic genome of future generations. Such
events during artificial evolution coincide with moments in which major changes occur to the
evolving species, causing new body parts or features to appear.
In biological terms, this means that the spreading in the genome of waves of new sets
of transposable elements in the course of evolution corresponds to moments in which new
branches (new species) are generated in the “tree of life”. Such predictions, made with our
model on purely theoretical grounds, appear to be confirmed by experimental evidence [25].
These observations suggest that the spreading of new transposon families in the genome
and the occurrence of major changes in the relevant lineage are simultaneous events. This
seems to hint that the colonisation of the genome by the transposons is the driving force
behind the change in the lineage. Our interpretation of this phenomenon is different. In
fact, according to ET, the spread of new transposon families in the genome is an event which
comes immediately (in evolutionary terms) after the change, not before. The confirmation
of this prediction, made possible by techniques to estimate the age of DNA sequences more
sensitive than those currently employed, would represent a clear indication in favour of this
model.
In conclusion, our model suggests a biological role for transposable elements which, as we
have seen, account for up to 40% of the genomic content in mammals. We argue that the
presence of trasposable elements is not an artifact, but an essential biological feature. In the
ET framework, for any individual, the set of mobile codes generated during development can
be divided into i) mobile codes that activate a macro gene during development and ii) mo-
bile codes that do not activate any macro gene during development. Indeed, the ET machine
cannot avoid generating inactive mobile codes. To prevent this effect we should reduce the
density of stem cells, but this would also reduce the effectiveness of the morphogenetic pro-
cess. Therefore, the presence of a certain amount of inactive mobile codes is unavoidable. On
this material intervenes germline penetration, converting inactive mobile codes into a corre-
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sponding number of inactive regulatory sets in the genome (the penetrated regulatory sets
are inactive because the associated switches are initially set to OFF). Therefore, the presence
of inactive information in both the set of mobile codes and the genome is a fact which is in-
escapably connected to the core of the ET machine, a requirement essential to its evolvability.
4 Ageing
Ageing is a universal phenomenon, for which many theories exist. Stochastic theories (e.g.
the “free-radical theory” [15]) blame damage induced by environmental factors, and accumu-
lating over time, as the cause of ageing. According to programmed theories (e.g. the “ageing-
clock theory” [5]), ageing is driven by genetic instructions, which can to a certain extent be
modulated by environmental conditions. Evolutionary theories (e.g. the “disposable soma
theory” [19]) see evolution as the main force shaping the ageing profile of different species.
A measure that was proved effective in reducing the rate of ageing in many species is
dietary restriction [23]. Many genes have been shown to influence the life span in some
species; most of these genes belong to the insulin / IGF1-like signalling pathway, to the class
of sirtuins, and to the target of rapamycin (TOR) pathway [18]. This last pathway is thought
to mediate the effects of dietary restriction at the cellular level. Overall, it is safe to say
that both genetic and environmental factors concur to cause ageing, but the balance between
these factors appears to change in the course of life: the first seem to prevail in the young,
the second become dominant in the old. We will now propose a possible explanation for this
phenomenon.
In ET, for a given individual development unfolds in N developmental stages; at the end of
it the individual’s fitness is evaluated, and used for reproduction in the genetic algorithm. The
moment of fitness evaluation, that in nature may correspond to the moment of reproduction,
in most of our experiments has coincided with the end of the simulation. On the other hand,
we can imagine to let the global clock tick on and see what happens in the period after fitness
evaluation. The distinction between the periods before and after fitness evaluation can be
thought to correspond to the biological periods of development (say, until 25 years of age in
humans) and ageing (from 25 years of age onwards).
At the end of an individual’s development, many stem cells are present in the body of the
individual. Some of these stem cells have been activated during development (and shaped
the individual’s body), some (the vast majority in our simulations) have not (Fig. 8). These
stem cells may contain genes bound to be activated in the ageing period, after the moment
of fitness evaluation (the moment of activation is determined by their timer value, ≥ 25)
when, by definition, they are not affecting the fitness value. For this reason, their coding
parts have not been optimised by evolution and the associated events will tend to have a
“pseudorandom” character, i.e. they will look random, even though they are not (they are
encoded in the genome and, as such, entirely under genetic control and deterministic).
The consequence of the “pseudorandomness” of these events is that their effects on the
overall individual’s health are more likely to be detrimental than beneficial. Here the term
“health” is used to indicate the individual “physical” condition, while the (reproductive) “fit-
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Figure 8: Stem cells present in ET artificial bodies at the end of development. Some of these stem
cells have been activated during development, some (the vast majority) have not. The timer value of
the gene which is going to be activated in each stem cell is indicated in the circles (numbers refer to
age in humans expressed in years).
Figure 9: In the upper panel: example of ageing in ET for a “face”. On the left the period of devel-
opment: the structure grows from a single cell to the mature phenotype at age 25 (red frame), when
fitness is evaluated. On the right the period of ageing: the quality of the structure deteriorates steadily
under the action of non-optimised genes. In the middle panel: the evolutionary pressure acting upon
a gene (represented by the darkness level) is an inversely proportional function of the timer value.
Genes with timer values lower than 25 years are subject to a high evolutionary pressure, genes with
timer values greater than 25 years are subject to a steadily decreasing pressure, until their effects be-
come pseudorandom. In the lower panel: the level of pseudorandomness (represented by the darkness
level) of a gene coding part increases with the gene timer value.
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ness” corresponds to the chance that the individual’s genes will survive in the future genetic
pool of the population. As a result, in the ageing period, the individual’s health will tend to
progressively decrease over time, under the action of such pseudorandom events. Therefore,
ET sees ageing as a continuation of development, driven by non-optimised genes activated in
specific stem cells after the age of reproduction. Our postulate is that these condiderations
apply also to biological ageing.
The hypothesis, according to which the evolutionary pressure acting on a gene is null if
it is activated after reproduction, is rather simplistic. In nature, an individual’s reproductive
fitness depends also on events manifesting themselves after reproduction, as also these affect
the survival chances of its progeny. More realistically, the effect of an event on the fitness (and
hence the evolutionary pressure acting upon the corresponding gene) will tend to decrease as
the age of its manifestation increases, rather than vanishing immediately after reproduction.
Figure 9 shows a simulation of ageing for a “face”, which incorporates this last observation.
The theory proposed provides a synthesis of all three categories of ageing theories. It has
a solid evolutionary background, and explains why the experimental evidence has a deter-
ministic connotation at young age and turns stochastic with age progression. It has also the
advantage to interpret development and ageing with a common theoretical framework. In
biology, besides proliferation and apoptosis, we can envision the existence of other types of
events. Another “biological change event” could induce epigenetic changes in the gene regu-
latory networks of affected cells. This, in turn, would change the biochemistry of the relevant
tissue and the function of the organ.
Another merit of our proposal is the involvement of stem cells in the picture. By analogy
with “cancer stem cells”, we may call the stem cells involved in the ageing process “ageing
stem cells”. There is empirical evidence of an age-related decline in the functionality of adult
stem cells [22]. Our hypothesis is that this functional decline is determined by epigenetic
changes induced in stem cells by biological change events, bound to occur at precise moments.
Such biological change events may occur both in stem cells activated during embryonic devel-
opment, and reactivated in the post-developmental period for tissue repair, or in stem cells
activated in the post-developmental period for the first time. Both types of events are hypoth-
esised to contribute to the ageing process.
The view of ageing as the progressive accumulation of pseudorandom events provides a
new interpretation for diseases typically associated to the old age (Alzheimer disease, type
II diabetes, etc.), which seem to be caused by the malfunctioning of specific genes, but whose
onset in humans typically occurs from the 5th decade of life onwards. Our hypothesis is that
the difference between these diseases and the effects of “normal”, “healthy”, ageing is more
quantitative than qualitative. We think that both ageing and ageing-associated diseases are
driven by biological change events caused by genes set to be activated in the old age: the
phenotipic manifestations of normal ageing are only milder, more benign than those associ-
ated to such diseases. This interpretation explains why the temporal patterns of ageing and
age-related diseases are coincident, and finds a strong confirmation in the fact that measures
known to delay ageing, such as caloric restriction, also postpone the onset of diseases [3].
As we mentioned, a slow-down in the pace of ageing can be obtained through dietary re-
Page 13 Compiled on 2018/11/17
5 CANCER
striction. One possible explanation of this evidence is that dietary restriction directly affects
the functioning of a biological equivalent of the global clock, which becomes slower. As a re-
sult, all genes bound to be activated in the ageing period are delayed, all by the same amount.
The genetic pathways known to influence life span may be part of the molecular device which
transduces the clock value (perhaps implemented as a diffusible molecule) from the external
cellular environment to the nucleus of cells.
5 Cancer
Cancer is a class of diseases involving unregulated cell growth. According to the “standard
theory”, also referred to as the “multi-hit” hypothesis [20], carcinogenesis is a multi-step pro-
cess that can take place in any cell, driven by multiple damages (“hits”) to genes that normally
regulate cell proliferation and cell death . An alternative theory considers cancer stem cells
responsible for tumour growth [1]. Cancer stem cells share with normal stem cells the ability
to self-renew and differentiate into multiple cell types: the presence in tumours of cells of
different types and/or having different degrees of differentiation is a well documented phe-
nomenon, coherent with the cancer stem cell theory.
In recent years, new cancer stem cell models have been proposed, e.g., the “complex sys-
tem model” [4], or the “stemness phenotype model” [21]. These models share the ideas that all
cells in a tumour are potentially tumorigenic, and that stemness is a dynamic property. The
stem-non stem conversion would occur in both directions, triggered by genetic and epigenetic
factors, and influenced by the cellular microenvironment.
A critical point for all cancer theories is the impossibility to reconduct tumour formation
to a common set of gene mutations. A few cancer-related genes, such as p53, do seem to be
mutated in the majority of tumours, but many other cancer genes are changed in only a small
fraction of cancer types, a minority of patients, or a subset of cells within a tumour. Although
the effort to reconduct tumour formation to subsets of mutated genes has been unsuccessful,
it is nonetheless undeniable that correlations between tumours and patterns of mutations
exist, i.e. individual genes are mutated in percentages that are tumour-specific [30].
As we have seen in section 2, ET foresees that each organ or anatomical structure of the
body is assembled, during embryogensis and during tissue regeneration, through the action
of MP modules and GF modules. If one or more such modules are damaged, the assembly
mechanism may not function properly.
If one or more MP modules are damaged, the mobile code generation device is impaired
(Fig. 10). As a result, mobile codes B necessary to issue the differentiation commands cannot
be created. Instead, mobile codes A are produced, which induce cells to keep proliferating.
The final outcome is an endless chain of proliferations of immature cells. A damage to MP
modules in our model may correspond in biology to mutations affecting genes involved in
MP pathways. Interestingly, genes belonging to such pathways are frequently mutated or
aberrantly activated in cancer [17].
In our interpretation, a fully working differentiation machinery requires the functioning
of all MP pathways involved in the generation of the organ. On the other hand, a reduced
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Figure 10: When one or more MP module are damaged, the mobile code generation device is impaired
(middle panel). As a result, mobile codes B necessary to issue the differentiation commands cannot
be created. Instead, mobile codes A are produced, which induce cells to keep proliferating: the final
outcome is an endless chain of proliferations of immature cells (lower panel). This, despite the fact
that cells preserve a normal response to proliferation and differentiation signals (upper panel).
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Figure 11: When the damage hits one or more GF modules, normal cells ignore commands coming
from stem cells (i.e. growth factors) and continue to proliferate under circumstances in which they
would normally exit the cell cycle and differentiate (upper panel). The final outcome is an endless
chain of proliferations of immature cells (lower panel). This, despite the fact that the normal-stem
mechanism is intact and the commands received by normal cells are correct (middle panel).
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form of differentiation can be obtained in many different ways, corresponding to all possible
different subsets of non-functional MP pathways. If a sufficient number of genes in one or
more MP pathways are rendered non-functional (through mutations), differentiation fails,
and cancer ensues.
Another dangerous situation occurs when the damage hits one or more GF modules (Fig. 11).
In this case, normal cells ignore commands coming from stem cells (i.e. growth factors) and
continue to proliferate under circumstances in which they would normally exit the cell cycle
and differentiate. Even in this case we can hypothesise that, while a fully working cellular
machinery requires the functioning of all GF pathways involved, a reduced form of function-
ing can be obtained in many different ways, corresponding to all possible different subsets of
non-functional GF pathways.
Table 2 refers to the same morphogens and growth factors listed in Table 1. The row la-
belled “combinations of damaged MP pathways” lists all possible combinations of damaged
MP pathways which lead to failed differentiation (and hence tumour formation) in the rel-
evant organ. Different combinations of damaged pathways may correspond to tumours of
different grades. Considering that a damage in each MP pathway can be caused by mutations
to a number of genes, this scheme can help to explain the heterogeneity of the mutational pat-
terns observed, and the presence in tumours of cells having different degrees of differentiation
and/or of different cell types. Analogous considerations can be applied to GF pathways.
organ organ 1 organ 2 organ 3 organ 4
morphogens involved a,b,c a,b,d a,c,d b,c,d
combinations of {a} {a} {a} {b}
damaged MP pathways {b} {b} {c} {c}
{c} {d} {d} {d}
{a,b} {a,b} {a,c} {b,c}
{a,c} {a,d} {a,d} {b,d}
{b,c} {b,d} {c,d} {c,d}
{a,b,c} {a,b,d} {a,c,d} {b,c,d}
growth factors involved p,q,r p,q,s p,r,s q,r,s
combinations of {p} {p} {p} {q}
damaged GF pathways {q} {q} {r} {r}
{r} {s} {s} {s}
{p,q} {p,q} {p,r} {q,r}
{p,r} {p,s} {p,s} {q,s}
{q,r} {q,s} {r,s} {r,s}
{p,q,r} {p,q,s} {p,r,s} {q,r,s}
Table 2: Hypothetical involvement of four MP pathways and four GF pathways in as four cancer types.
Based on this scheme, “driver” mutations found in cancer samples can be divided in three
broad categories: mutations to MP pathways, mutations to GF pathways, and mutations to
other genes, which confer to the trasformed cell the ability to acquire a fully malignant phe-
notype, to invade and infiltrate distant tissues. Our model predicts that each cancer harbors
mutations in one or more MP pathways and/or one or more GF pathways, and the number of
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damaged pathways be proportional to the phenotypic “distance” of the tumour from its normal
counterpart, i.e. inversely proportional to the tumour grade.
Based on studies of skin cancer, the process of carcinogenesis is traditionally divided into
three phases: initiation (induction of permanent alterations to DNA), promotion (proliferation
of the initiated cell triggered by subsequent stimuli) and progression (from a benign tumour
to a malignant one). Our interpretation is that damages to MP and GF pathways correspond
to initiation, the first stage of carcinogenesis. The analogous in our model of the promotion
phase, i.e. the proliferation of the stem cell, is postponed until regeneration occurs, or until
the clock reaches the timer value. The action of a timer-dependent mechanism, if present in
biology, may explain the long latency period observed between the exposure to carcinogenic
substances (e.g. tobacco smoke) and the appearance of a tumour (e.g. lung cancer). Finally,
progression, the third and last phase of carcinogenesis, may be linked to further mutations
which confer additional powers to the already transformed cells, i.e. the capacity to infiltrate
tissues and to produce distant metastases.
Our proposal is fully consistent with the cancer stem cell model, with the recent paradigm
of dynamic stemness, and with the idea that each cell in a tumour has tumorigenic potential.
This potential is associated to a damage to MP or GF genes, which is present initially in a
single stem cell, and subsequently spreads to all normal and stem cells derived from it. The
ET contribution to the field mainly lies in two ideas. The first idea consists in the notion of
stem cell generation, which explains the emergence of a hierarchy of cell types, and brings
together embryonic, adult and cancer stem cells under a unified framework. The second idea
is a proposal for a low-level generation mechanism, through the actions of morphogens and
growth factors.
6 Conclusions
We wish to conclude this summary indicating some experiments that could be used to test ET.
One of the pillars of the model is the dynamic nature of the normal-stem transition. Stem cells
can generate normal cells, and normal cells can revert to stem cells, with a new mobile code.
This provides a conceptual bridge that links together embryonic, adult, ageing and cancer
stem cells, and explains the emergence of a hierarchy of stem cells, a fact corroborated by data
on numerous organs or biological subsystems. In order to validate the model, it is necessary to
reproduce the biochemical mechanism which enables the normal-stem conversion, and shed
light on the interplay between MP pathways and Hox genes, which is deemed responsible for
mobile code generation.
As we have seen in section 3, germline penetration implements a flow of genetic informa-
tion from somatic to germline cells, to be passed on to future generations: as such, it can be
considered the carrier of a transposon-mediated inheritance device. As a first step to prove
the existence of the flow, we need to identify the moment in which transposable elements
exit their host stem cells to reach the circulatory system, and make their way towards the
germline. Furthermore, our model predicts that the spread of transposons is an event which
immediately (in evolutionary terms) follows a lineage change. This could be done through
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techniques for estimating the age of DNA sequences more sentitive than those currently in
use.
In section 5 we have proposed an explanation for the heterogeneity of patterns of gene mu-
tations observed in different tumours. The explanation is based on a hypothetical differential
involvement of MP and GF pathways in the generation (and regeneration) of different organs.
This prediction is susceptible of verification with bioinformatical techniques. To achieve this
objective, MP and GF genes should be screened for their mutation rates associated to various
types of cancer.
In conclusion, we have shown that ET is able to generate arbitrary 3-dimensional cellu-
lar structures of unprecedented complexity, and can reproduce a simplified version of some
key biological phenomena such as development, the presence of transposable elements in the
genome, ageing and cancer. For this reason, we think it can be proposed as a general-purpose
model for multicellular biology. Future work will be aimed at further reducing the biological
gap, mapping the model variables to individual genes and chemical elements.
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